The Potential of Tricaprin in Preventing the Development Of AAA
Kugo, Hirona, et al. Biomedicine & Pharmacotherapy, 2023, 160, 114299.
Medium-chain triglycerides (MCT) are composed of medium-chain fatty acids (MCFA) with a backbone of 8-10 carbon atoms. MCTs are used clinically to treat metabolic and neurological diseases, and their safety has been demonstrated. Recently, studies have used aortic hypoperfusion-induced abdominal aortic aneurysm (AAA) models to identify AAA drug candidates.
Effects of MCT on AAA
· Tricaprin can be effective to prevent or treat abdominal aortic aneurysm.
· Tricaprin can suppress smooth muscle cells dysfunction in the aortic wall.
· Tricaprin can have potent pre-clinical activities, but not tricaprylin.
· Tricaprin can be a promising candidate to reduce the risk of AAA rupture.